Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
44 Cards in this Set
- Front
- Back
What is the spectrum of activity of amphotericin B?
|
Aspergillus, candida, histoplasma, blastomyces, fusarium, zygomycetes
|
|
What is a significant side effect of amphotericin B?
|
Nephrotoxicity
|
|
Which formulation of amphotericin B would you prefer for pulmonary Aspergillus?
|
Lipid complex (ABLC)
|
|
Which formulation of amphotericin B would you prefer for CNS Aspergillus?
|
Liposomal (L-AmB)
|
|
Which of the four azoles has the broadest spectrum?
|
Voriconazole
|
|
What is voriconazole's spectrum?
|
Most candida
Aspergillus (DoC) Fusarium |
|
What is the IV dosing for voriconazole?
|
6 mg/kg Q12h x 2, then
4 mg/kg Q12h |
|
What is the PO dosing for voriconazole?
|
If > 40kg, then 200mg PO
If < 40kg, then 100mg PO |
|
What is the spectrum for posaconazole?
|
Aspergillus
Refractory candida Histoplasmosis Fusarium |
|
What is the prophylaxis dosage for posaconazole?
|
200mg TID
|
|
What is the treatment dosage for posaconazole?
|
200mg QID
|
|
What is the spectrum for fluconazole?
|
C. albicans
C. tropicalis (lesser extent, C. glabrata) |
|
True or False - Fluconazole covers Aspergillus
|
False
|
|
True or False - Fluconazole has excellent CSF penetration
|
True
|
|
Which azoles have strong 3A4 inhibition?
|
Voriconazole
Itraconazole |
|
What is the spectrum for itraconazole?
|
C. albicans
C. tropicalis C. glabrata Aspergillus |
|
True or False - Itraconazole has excellent CSF penetration
|
False - poor penetration
|
|
True or False - Fluconazole is a strong 3A4 inhibitor
|
False - it is a weak 3A4 inhibitor
|
|
What is the spectrum for caspofungin?
(be sure to include which candida strains are not covered) |
Most candida (not really Krusei or Parapsilosis)
Aspergillus Histoplasma |
|
What is the dosing for caspofungin?
|
70mg IV LD, then 50mg IV daily
|
|
What is the dosing of micafungin in...
Candidemia, disseminated candidemia? Esophageal candidiasis? Prophylaxis of candidiasis in HSCT? |
100mg IV daily
150mg IV daily 50mg IV daily |
|
What is the DoC for C. albicans?
|
Fluconazole
|
|
What is the DoC for C. glabrata?
|
Echinocandin (caspofungin)
|
|
What is the DoC for C. parapsilosis?
|
Fluconazole
|
|
What is the DoC for C. tropicalis?
|
Fluconazole
|
|
What is the DoC for C. krusei?
|
Echinocandin (caspofungin)
|
|
What is the drug of choice in Aspergillus? Dose?
|
Voriconazole
6 mg/kg IV Q12h for one day, then 4 mg/kg IV Q12h |
|
What is the regular dose for LAMB?
|
3-5 mg/kg/day
|
|
What is the regular dose for ABLC?
|
5 mg/kg/day
|
|
What is the duration of therapy for Invasive Pulmonary Aspergillus?
|
6-12 weeks
|
|
Which organism has hyphae?
|
Zygomycetes (mucormycosis, zygomycosis = rhizo)
|
|
What is the treatment regimen for Zygomycetes?
|
LAMB 5 mg/kg
+/- Posaconazole 200mg PO QID |
|
Which azole has the poorest bioavailability?
|
Itraconazole
|
|
What type of environment does itraconazole require (capsules, solution)?
|
Capsules - acidic
Solution - basic |
|
What type of environment does posaconazole require for absorption?
|
High fat, high acid
|
|
Aspergillus terreus is resistant to what drug?
|
Amphotericin
|
|
What is an important side effect with voriconazole?
|
Visual disturbances - seen within first few weeks of therapy
|
|
What are target trough concentrations for voriconazole?
|
> 2 mcg/mL
(less than this is associated with breakthrough infections) |
|
Caution should be exercised when using IV voriconazole in patients with what clinical status and why?
|
Renal failure (CrCl < 50) - the vehicle can cause further damage
|
|
What are target trough concentrations with posaconazole?
|
> 1.25 mcg/mL
|
|
What is the dosing for treatment of mucormycosis?
|
Posaconazole 200mg QID
|
|
What is the dosing for prophylaxis of mucormycosis?
|
Posaconazole 200mg TID
|
|
Which amphotericin B formulation can be used in Aspergillus?
|
Liposomal (L-AmB), and only after voriconazole
|
|
What are the risk factors for fungal infections?
|
Underlying host defects (neutropenia, T cell and B cell dysfunction, immunosuppression, transplantation, AIDS, diabetes), cytotoxic chemotherapy, high dose corticosteroids, GVHD, long-term broad-spectrum ABs, prolonged hospitalization (including catheters), burns
|